Female Sexual Arousal Disorder Clinical Trial
Official title:
A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sildenafil Cream, 3.6% in Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)
This study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by providing a topical preparation of Sildenafil locally to the vulvar-vaginal tissue.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03820453 -
Clinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Function in Postmenopausal Women.
|
N/A | |
| Completed |
NCT02958176 -
Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
|
N/A | |
| Terminated |
NCT00572377 -
Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder
|
Phase 1 | |
| Completed |
NCT01382719 -
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
|
Phase 2 | |
| Completed |
NCT05685407 -
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
|
Phase 1 | |
| Terminated |
NCT03682601 -
Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
|
Phase 2 | |
| Completed |
NCT01803802 -
Effects of Early Abuse on Adult Intimate Relationships
|
N/A | |
| Completed |
NCT00640458 -
Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder
|
Phase 2 | |
| Not yet recruiting |
NCT06116045 -
Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
|
Phase 2 |